TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial.

Elias K Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.